dysprosium has been researched along with Myocardial Ischemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nilsson, S | 1 |
| Beache, GM; Brady, TJ; Campbell, TA; Chesler, DA; Gewirtz, H; Kantor, HL; Kulke, SF; Niemi, P; Rosen, BR; Weisskoff, RM | 1 |
| Higgins, CB; Lund, G; Saeed, M; Wendland, MF | 1 |
1 review(s) available for dysprosium and Myocardial Ischemia
| Article | Year |
|---|---|
Contrast-enhanced MRI for quantification of myocardial viability.
Topics: Animals; Contrast Media; Dysprosium; Edetic Acid; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Manganese; Myocardial Ischemia; Myocardial Stunning; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate | 1999 |
2 other study(ies) available for dysprosium and Myocardial Ischemia
| Article | Year |
|---|---|
MR imaging of contrast-enhanced porcine myocardial infarction. Assessment of reperfusion and tissue viability.
Topics: Analysis of Variance; Animals; Contrast Media; Diagnosis, Differential; Dysprosium; Evaluation Studies as Topic; Female; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Organometallic Compounds; Pentetic Acid; Swine; Time Factors; Tissue Survival | 1995 |
Imaging perfusion deficits in ischemic heart disease with susceptibility-enhanced T2-weighted MRI: preliminary human studies.
Topics: Adult; Aged; Artifacts; Contrast Media; Dysprosium; Feasibility Studies; Female; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Pentetic Acid; Sensitivity and Specificity | 1998 |